Shock Energy for Electrical Cardioversion of Persistent Atrial Fibrillation

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 100 participants.

Also called NCT05903170

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 100 participants (planned count) (from the registry)
Sponsor
Wellington Hospital (from the registry)
Registry
  • NCT NCT05903170
Planned start
(anticipated) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
New Zealand (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT05903170. Randomized; no masking; primary purpose treatment. Start 2025-08 (anticipated); primary completion 2026-05 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Shock Energy for Electrical Cardioversion of Persistent Atrial Fibrillation
Intervention (Device)
360J LifePak Monitor/Defibrillator
Intervention (Device)
200J Philips HeartStart MRx Monitor/Defibrillator
Lead sponsor
Wellington Hospital (class: other government)

Record details

Record id
cardio:ct-nct05903170
Content hash
3037eb70ca8218e2e57ccde0896275249907788412b405034b161b1e980f76c5